New glioblastoma drug (IMAGE)

Keck School of Medicine of USC

New glioblastoma drug

Caption

A new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials.

Credit

Issey Takahashi

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.